The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125424401 12542440 1 I 20140819 20141006 20160708 20160708 EXP AT-ASTRAZENECA-2014SE76909 ASTRAZENECA 54.00 YR F Y 0.00000 20160709 OT AT AT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125424401 12542440 1 PS SEROQUEL QUETIAPINE FUMARATE 1 Oral 44600 MG Y 20639 300 MG PROLONGED-RELEASE TABLET QD
125424401 12542440 2 SS SEROQUEL QUETIAPINE FUMARATE 1 Oral 44600 MG Y 20639 500 MG PROLONGED-RELEASE TABLET QD
125424401 12542440 3 SS SEROQUEL QUETIAPINE FUMARATE 1 Oral 44600 MG Y 20639 200 MG TABLET QD
125424401 12542440 4 SS PROPOFOL. PROPOFOL 1 Intravenous (not otherwise specified) U U 0 ORAL EMULSION
125424401 12542440 5 SS ABILIFY ARIPIPRAZOLE 1 Intramuscular 7.5MG ONCE/SINGLE ADMINISTRATION Y 0 7.5 MG INJECTION
125424401 12542440 6 SS ABILIFY ARIPIPRAZOLE 1 Intramuscular 7.5-40 MG ONCE/SINGLE ADMINISTRATION Y 0 INJECTION
125424401 12542440 7 SS TRITTICO RETARD TRAZODONE HYDROCHLORIDE 1 Oral 25500 MG Y 0 300 MG QD
125424401 12542440 8 SS RISPERDAL RISPERIDONE 1 Oral 552 MG Y 0 6 MG QD
125424401 12542440 9 C SIMAVASTAD 2 Oral 0 40 MG QD
125424401 12542440 10 C EUCREAS METFORMIN HYDROCHLORIDEVILDAGLIPTIN 1 Oral 100/200 MG DAILY 0 TABLET
125424401 12542440 11 C DIAMICRON GLICLAZIDE 1 Oral 0 60 MG QD
125424401 12542440 12 C ACEMIN LISINOPRIL 1 Oral 0 2.5 MG QD
125424401 12542440 13 C CONCOR BISOPROLOL FUMARATE 1 Oral 0 2.5 MG TABLET QD
125424401 12542440 14 C CONCOR BISOPROLOL FUMARATE 1 Oral 0 TABLET
125424401 12542440 15 C TEMESTA LORAZEPAM 1 Oral 0 2 MG QD
125424401 12542440 16 C TEMESTA LORAZEPAM 1 Oral 2-10 MG 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125424401 12542440 4 Agitation
125424401 12542440 10 Diabetes mellitus
125424401 12542440 11 Diabetes mellitus
125424401 12542440 12 Hypertension
125424401 12542440 13 Hypertension
125424401 12542440 14 Hypertension

Outcome of event

Event ID CASEID OUTC COD
125424401 12542440 HO
125424401 12542440 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125424401 12542440 Blood magnesium decreased
125424401 12542440 Blood pressure increased
125424401 12542440 Diabetes mellitus inadequate control
125424401 12542440 Electrocardiogram QT prolonged
125424401 12542440 Intentional product misuse
125424401 12542440 Off label use
125424401 12542440 Sinus tachycardia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125424401 12542440 1 20140505 20140717 0
125424401 12542440 2 20140718 20140818 0
125424401 12542440 3 20140718 20140818 0
125424401 12542440 5 20140819 20140819 0
125424401 12542440 7 20140526 20140818 0
125424401 12542440 8 20140519 20140818 0
125424401 12542440 9 20140505 20140818 0
125424401 12542440 10 20140506 20140818 0
125424401 12542440 11 20140602 20140818 0
125424401 12542440 12 20140528 20140818 0
125424401 12542440 13 20140521 20140818 0
125424401 12542440 15 20140819 20140819 0
125424401 12542440 16 20140820 0